The ENERGY trial
20 Jun 2011
The ENERGY trial
Advances in breast cancer research from ASCO 2011
PTEN expression does not diminish trastuzumab effectiveness
Cancer prevention through education
Exemestane significantly reduces risk of invasive breast cancer in high-risk, postmenopausal women
Susan G. Komen for the Cure; worldwide breast cancer advocacy
ASCO 2011 highlights
Partial breast irradiation
Impact of waiting times in head and neck cancer
Reducing global cancer mortality
Breast cancer and early cancer detection in Oman
Public-private partnerships in personalised medicine